Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole

• Status: Completed
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators propose the evaluation of posaconazole and benznidazole in humans for the treatment of Chagas disease chronical infection. Exploratory trial of posaconazole antiparasitic activity against Trypanosoma cruzi.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute
• Collaborators: Hospital Vall d'Hebron; International Health Unit Metropolitana Nord. Santa Coloma.; Tropical Medicine and International Health Unit Drassanes. Barcelona
• Treatments: Benzonidazole; Posaconazole

Criteria

Inclusion Criteria:

• Consenting patients with serological evidence of Chagas infection and positive PCR real time

Exclusion Criteria:

-